Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Quantitative MRI and Cerebrospinal Fluid Inflammatory Mediators in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis before and after Treatment with Immunomodulators: A Longitudinal Study.
The olfactory vector hypothesis of neurodegenerative disease: is it viable?
Epistasis and immunity: the role of genetic interactions in autoimmune diseases.
The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis.
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis.
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
Functional role of TRP channels in modulating ER stress and Autophagy.
Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis.
Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study.
Assessing the impact of multiple sclerosis disease activity and daclizumab HYP treatment on patient-reported outcomes: Results from the SELECT trial.
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man.
Partnering to increase access to community exercise programs for people with stroke, acquired brain injury, and multiple sclerosis.
Prospective Examination of Anxiety and Depression Before and During Confirmed and Pseudoexacerbations in Patients With Multiple Sclerosis.
Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study.
Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS] (RECYCLINE)
Myelination of the nervous system: mechanisms and functions.
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.
Patient perceptions of multiple sclerosis and its treatment.
Eosinophilic Fasciitis Occurring under Treatment with Natalizumab for Multiple Sclerosis.
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis?
Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis.
What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature.
Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells.
Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, th17- and activated B-cells and correlates with progression.

Pages